Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NITROGLYCERIN Cause Cardiac failure congestive? 107 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 107 reports of Cardiac failure congestive have been filed in association with NITROGLYCERIN (Glonoinum). This represents 1.4% of all adverse event reports for NITROGLYCERIN.

107
Reports of Cardiac failure congestive with NITROGLYCERIN
1.4%
of all NITROGLYCERIN reports
30
Deaths
86
Hospitalizations

How Dangerous Is Cardiac failure congestive From NITROGLYCERIN?

Of the 107 reports, 30 (28.0%) resulted in death, 86 (80.4%) required hospitalization, and 22 (20.6%) were considered life-threatening.

Is Cardiac failure congestive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NITROGLYCERIN. However, 107 reports have been filed with the FAERS database.

What Other Side Effects Does NITROGLYCERIN Cause?

Drug ineffective (1,269) Fall (1,183) Hypotension (1,086) Pain (952) Constipation (896) Headache (890) Dyspnoea (801) Malaise (765) Dizziness (717) Fatigue (680)

What Other Drugs Cause Cardiac failure congestive?

ROSIGLITAZONE (15,085) METFORMIN\ROSIGLITAZONE (1,408) LENALIDOMIDE (1,373) AMBRISENTAN (1,359) SACUBITRIL\VALSARTAN (1,355) APIXABAN (1,144) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (1,129) AVANDIA (1,102) ADALIMUMAB (990) MACITENTAN (979)

Which NITROGLYCERIN Alternatives Have Lower Cardiac failure congestive Risk?

NITROGLYCERIN vs NITROUS NITROGLYCERIN vs NITROUS\OXYGEN NITROGLYCERIN vs NIVOLUMAB NITROGLYCERIN vs NIVOLUMAB\RELATLIMAB-RMBW NITROGLYCERIN vs NIZATIDINE

Related Pages

NITROGLYCERIN Full Profile All Cardiac failure congestive Reports All Drugs Causing Cardiac failure congestive NITROGLYCERIN Demographics